{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:47:50Z","timestamp":1776494870476,"version":"3.51.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Collagen VI family (COL6A) is a major member of extracellular matrix protein. There is accumulating evidence that COL6A is involved in tumorigenesis and tumor progression. In this study, we performed a systematic analysis of COL6A in pan-cancer based on their molecular features and clinical significance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Based on updated public databases, we integrated several bioinformatics analysis methods to investigate the expression levels of COL6A as well as the relationship between their expression and patient survival, immune subtypes, tumor microenvironment, stemness scores, drug sensitivity, and DNA methylation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The expression levels of COL6A members varied in different cancers, suggesting their expression was cancer-dependent. Among COL6A members, COL6A1\/2\/3 were predicted poor prognosis in specific cancers. Furthermore, COL6A1\/2\/3 expression levels revealed a clear correlation with immune subtypes, and COL6A1\/2\/3 were associated with tumor purity, that is, gene expression levels were generally higher in tumors with higher stromal scores and immune scores. COL6A1\/2\/3 had a significantly negative correlation with RNA stemness scores, and meanwhile they were also related to DNA stemness scores in different degrees. In addition, the expression of COL6A1\/2\/3 was significantly related to drug sensitivity of cancer cells. Finally, our study revealed that COL6A1\/2\/3 expression was mainly negatively correlated with gene methylation, and the methylation levels showed remarkable differences in various cancers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings highlight both the similarities and differences in the molecular characteristics of COL6A members in pan-cancer, and provide comprehensive insights for further investigation into the mechanism of COL6A.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12859-022-04951-0","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T08:03:05Z","timestamp":1664265785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["A pan-cancer analysis of collagen VI family on prognosis, tumor microenvironment, and its potential therapeutic effect"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanzhi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"issue":"1","key":"4951_CR1","first-page":"105","volume":"1805","author":"A Marusyk","year":"2010","unstructured":"Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences. Biochim Biophys Acta. 2010;1805(1):105\u201317.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"4951_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.celrep.2018.03.063","volume":"23","author":"JD Campbell","year":"2018","unstructured":"Campbell JD, Yau C, Bowlby R, Liu Y, Brennan K, Fan H, et al. Genomic, pathway network, and immunologic features distinguishing squamous carcinomas. Cell Rep. 2018;23(1):194\u2013212.","journal-title":"Cell Rep"},{"issue":"4","key":"4951_CR3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ccell.2018.03.010","volume":"33","author":"Y Liu","year":"2018","unstructured":"Liu Y, Sethi NS, Hinoue T, Schneider BG, Cherniack AD, Sanchez-Vega F, et al. Comparative molecular analysis of gastrointestinal adenocarcinomas. Cancer Cell. 2018;33(4):721\u201335.","journal-title":"Cancer Cell"},{"key":"4951_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","volume":"387","author":"T Wu","year":"2017","unstructured":"Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett. 2017;387:61\u20138.","journal-title":"Cancer Lett"},{"issue":"3","key":"4951_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10585-019-09966-1","volume":"36","author":"JA Eble","year":"2019","unstructured":"Eble JA, Niland S. The extracellular matrix in tumor progression and metastasis. Clin Exp Metastasis. 2019;36(3):171\u201398.","journal-title":"Clin Exp Metastasis"},{"issue":"16","key":"4951_CR6","doi-asserted-by":"publisher","first-page":"10658","DOI":"10.1074\/jbc.M709540200","volume":"283","author":"SK Gara","year":"2008","unstructured":"Gara SK, Grumati P, Urciuolo A, Bonaldo P, Kobbe B, Koch M, et al. Three novel collagen VI chains with high homology to the alpha3 chain. J Biol Chem. 2008;283(16):10658\u201370.","journal-title":"J Biol Chem"},{"issue":"29","key":"4951_CR7","doi-asserted-by":"publisher","first-page":"20170","DOI":"10.1074\/jbc.M710139200","volume":"283","author":"J Fitzgerald","year":"2008","unstructured":"Fitzgerald J, Rich C, Zhou FH, Hansen U. Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI). J Biol Chem. 2008;283(29):20170\u201380.","journal-title":"J Biol Chem"},{"issue":"17","key":"4951_CR8","doi-asserted-by":"publisher","first-page":"15326","DOI":"10.1074\/jbc.M209977200","volume":"278","author":"S Ball","year":"2003","unstructured":"Ball S, Bella J, Kielty C, Shuttleworth A. Structural basis of type VI collagen dimer formation. J Biol Chem. 2003;278(17):15326\u201332.","journal-title":"J Biol Chem"},{"issue":"3","key":"4951_CR9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1158\/0008-5472.CAN-03-2408","volume":"64","author":"A Nanda","year":"2004","unstructured":"Nanda A, Carson-Walter EB, Seaman S, Barber TD, Stampfl J, Singh S, et al. TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI). Cancer Res. 2004;64(3):817\u201320.","journal-title":"Cancer Res"},{"issue":"5","key":"4951_CR10","first-page":"2297","volume":"44","author":"T Sato","year":"2020","unstructured":"Sato T, Tokunaka K, Saiga K, Tomura A, Sugihara H, Hayashi T, Imamura Y, Morita M, et al. Involvement of non-triple helical type\u00a0VI collagen\u00a0\u03b11 chain, NTH\u00a0\u03b11(VI), in the proliferation of cancer cells. Oncol Rep. 2020;44(5):2297\u2013305.","journal-title":"Oncol Rep"},{"issue":"3","key":"4951_CR11","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.7150\/thno.51245","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Liu Z, Yang X, Lu W, Chen Y, Lin Y, et al. H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts. Theranostics. 2021;11(3):1473\u201392.","journal-title":"Theranostics"},{"issue":"5","key":"4951_CR12","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1172\/JCI23424","volume":"115","author":"P Iyengar","year":"2005","unstructured":"Iyengar P, Espina V, Williams TW, Lin Y, Berry D, Jelicks LA, et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor\/stroma microenvironment. J Clin Invest. 2005;115(5):1163\u201376.","journal-title":"J Clin Invest"},{"issue":"2","key":"4951_CR13","first-page":"391","volume":"55","author":"KG Owusu-Ansah","year":"2019","unstructured":"Owusu-Ansah KG, Song G, Chen R, Edoo MIA, Li J, Chen B, et al. COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer. Int J Oncol. 2019;55(2):391\u2013404.","journal-title":"Int J Oncol"},{"issue":"4","key":"4951_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3892\/ol.2021.12954","volume":"22","author":"N Li","year":"2021","unstructured":"Li N, Liu M, Cao X, Li W, Li Y, Zhao Z. Identification of differentially expressed genes using microarray analysis and COL6A1 induction of bone metastasis in non-small cell lung cancer. Oncol Lett. 2021;22(4):693.","journal-title":"Oncol Lett"},{"issue":"1","key":"4951_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3892\/ijo.2021.5217","volume":"59","author":"XM Piao","year":"2021","unstructured":"Piao XM, Hwang B, Jeong P, Byun YJ, Kang HW, Seo SP, et al. Collagen type VI-\u03b11 and 2 repress the proliferation, migration and invasion of bladder cancer cells. Int J Oncol. 2021;59(1):37.","journal-title":"Int J Oncol"},{"issue":"20","key":"4951_CR16","doi-asserted-by":"publisher","first-page":"8845","DOI":"10.18632\/aging.102300","volume":"11","author":"R Long","year":"2019","unstructured":"Long R, Liu Z, Li J, Yu H. COL6A6 interacted with P4HA3 to suppress the growth and metastasis of pituitary adenoma via blocking PI3K-Akt pathway. Aging (Albany NY). 2019;11(20):8845\u201359.","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"4951_CR17","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.molmed.2013.04.001","volume":"19","author":"P Chen","year":"2013","unstructured":"Chen P, Cescon M, Bonaldo P. Collagen VI in cancer and its biological mechanisms. Trends Mol Med. 2013;19(7):410\u20137.","journal-title":"Trends Mol Med"},{"issue":"10","key":"4951_CR18","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013;45(10):1113\u201320.","journal-title":"Nat Genet"},{"issue":"1","key":"4951_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/pro.3307","volume":"27","author":"PJ Thul","year":"2018","unstructured":"Thul PJ, Lindskog C. The human protein atlas: A spatial map of the human proteome. Protein Sci. 2018;27(1):233\u201344.","journal-title":"Protein Sci"},{"issue":"7391","key":"4951_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483(7391):603\u20137.","journal-title":"Nature"},{"issue":"4","key":"4951_CR21","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, et al. The immune landscape of cancer. Immunity. 2018;48(4):812\u201330.","journal-title":"Immunity"},{"key":"4951_CR22","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"2","key":"4951_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173(2):338\u201354.","journal-title":"Cell"},{"issue":"14","key":"4951_CR24","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1158\/0008-5472.CAN-12-1370","volume":"72","author":"WC Reinhold","year":"2012","unstructured":"Reinhold WC, Sunshine M, Liu H, Varma S, Kohn KW, Morris J, et al. Cell Miner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res. 2012;72(14):3499\u2013511.","journal-title":"Cancer Res"},{"issue":"21","key":"4951_CR25","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","volume":"34","author":"CJ Liu","year":"2018","unstructured":"Liu CJ, Hu FF, Xia MX, Han L, Zhang Q, Guo AY. GSCALite: a web server for gene set cancer analysis. Bioinformatics. 2018;34(21):3771\u20132.","journal-title":"Bioinformatics"},{"issue":"6472","key":"4951_CR26","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1126\/science.aav1741","volume":"366","author":"SE McGeary","year":"2019","unstructured":"McGeary SE, Lin KS, Shi CY, Pham TM, Bisaria N, Kelley GM, et al. The biochemical basis of microRNA targeting efficacy. Science. 2019;366(6472):1741.","journal-title":"Science"},{"key":"4951_CR27","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.12659\/MSM.909811","volume":"24","author":"Y Huang","year":"2018","unstructured":"Huang Y, Li G, Wang K, Mu Z, Xie Q, Qu H, et al. Collagen type VI alpha 3 chain promotes epithelial-mesenchymal transition in bladder cancer cells via transforming growth factor \u03b2 (TGF-\u03b2)\/smad pathway. Med Sci Monit. 2018;24:5346\u201354.","journal-title":"Med Sci Monit"},{"issue":"6","key":"4951_CR28","first-page":"2838","volume":"8","author":"T Hou","year":"2016","unstructured":"Hou T, Tong C, Kazobinka G, Zhang W, Huang X, Huang Y, et al. Expression of COL6A1 predicts prognosis in cervical cancer patients. Am J Transl Res. 2016;8(6):2838\u201344.","journal-title":"Am J Transl Res"},{"issue":"43","key":"4951_CR29","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1126\/sciadv.abc3175","volume":"6","author":"AL Wishart","year":"2020","unstructured":"Wishart AL, Conner SJ, Guarin JR, Fatherree JP, Peng Y, McGinn RA, et al. Decellularized extracellular matrix scaffolds identify full-length collagen VI as a driver of breast cancer cell invasion in obesity and metastasis. Sci Adv. 2020;6(43):3715.","journal-title":"Sci Adv"},{"issue":"8","key":"4951_CR30","doi-asserted-by":"publisher","first-page":"5707","DOI":"10.4049\/jimmunol.180.8.5707","volume":"180","author":"M Schnoor","year":"2008","unstructured":"Schnoor M, Cullen P, Lorkowski J, Stolle K, Robenek H, Troyer D, et al. Production of type VI collagen by human macrophages: a new dimension in macrophage functional heterogeneity. J Immunol. 2008;180(8):5707\u201319.","journal-title":"J Immunol"},{"issue":"6","key":"4951_CR31","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","volume":"10","author":"JE Visvader","year":"2012","unstructured":"Visvader JE, Lindeman GJ. Cancer stem cells: current status and evolving complexities. Cell Stem Cell. 2012;10(6):717\u201328.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"4951_CR32","first-page":"668","volume":"11","author":"CM Ho","year":"2021","unstructured":"Ho CM, Chang TH, Yen TL, Hong KJ, Huang SH. Collagen type VI regulates the CDK4\/6-p-Rb signaling pathway and promotes ovarian cancer invasiveness, stemness, and metastasis. Am Cancer Res. 2021;11(3):668\u201390.","journal-title":"Am Cancer Res"},{"issue":"18","key":"4951_CR33","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1158\/0008-5472.CAN-13-1080","volume":"73","author":"D Chen","year":"2013","unstructured":"Chen D, Bhat-Nakshatri P, Goswami C, Badve S, Nakshatri H. ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer. Cancer Res. 2013;73(18):5821\u201333.","journal-title":"Cancer Res"},{"issue":"1","key":"4951_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12964-020-00646-2","volume":"18","author":"P Yin","year":"2020","unstructured":"Yin P, Bai Y, Wang Z, Sun Y, Gao J, Na L, et al. Non-canonical Fzd7 signaling contributes to breast cancer mesenchymal-like stemness involving Col6a1. Cell Commun Signal. 2020;18(1):143.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"4951_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1535-6108(03)00058-8","volume":"3","author":"CA Sherman-Baust","year":"2003","unstructured":"Sherman-Baust CA, Weeraratna AT, Rangel LB, Pizer ES, Cho KR, Schwartz DR, et al. Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. Cancer Cell. 2003;3(4):377\u201386.","journal-title":"Cancer Cell"},{"issue":"6","key":"4951_CR36","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/emmm.201202006","volume":"5","author":"J Park","year":"2013","unstructured":"Park J, Morley TS, Scherer PE. Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours. EMBO Mol Med. 2013;5(6):935\u201348.","journal-title":"EMBO Mol Med"},{"issue":"4","key":"4951_CR37","first-page":"925","volume":"14","author":"RR Varma","year":"2005","unstructured":"Varma RR, Hector SM, Clark K, Greco WR, Hawthorn L, Pendyala L. Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780\/C10. Oncol Rep. 2005;14(4):925\u201332.","journal-title":"Oncol Rep"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-022-04951-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-022-04951-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-022-04951-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T08:07:21Z","timestamp":1664266041000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-022-04951-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4951"],"URL":"https:\/\/doi.org\/10.1186\/s12859-022-04951-0","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"assertion":[{"value":"10 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"390"}}